Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy-Reference-Cited by-同舟云学术

Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy

Published:2015-10-12 Issue:5 Volume:36 Page:688-695
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Finkenstedt Armin¹,Vikoler Anja¹,Portenkirchner Manuela²,Mülleder Kerstin²,Maglione Manuel³,Margreiter Christian³,Moser Patrizia⁴,Vogel Wolfgang¹,Bale Reto²,Freund Martin²,Luger Anna²,Tilg Herbert⁵,Petersen Johannes²,Schneeberger Stefan³,Graziadei Ivo⁶,Zoller Heinz¹,Glodny Bernhard²

Affiliation:

1. Department of Medicine II, Gastroenterology and Hepatology; Medical University of Innsbruck; Innsbruck Austria

2. Department of Radiology; Medical University of Innsbruck; Innsbruck Austria

3. Department of Transplant Surgery; Medical University Innsbruck; Innsbruck Austria

4. Department of Pathology; Medical University Innsbruck; Innsbruck Austria

5. Department of Medicine I, Gastroenterology and Hepatology; Medical University of Innsbruck; Innsbruck Austria

6. Department of Internal Medicine; Academic Teaching Hospital Hall in Tirol; Hall Austria

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12966/fullpdf

Reference26 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver;Bruix;J Hepatol,2001

3. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

4. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list;Yao;Liver Transpl,2002

5. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis;Mazzaferro;Lancet Oncol,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02

3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

4. Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts;Cancers;2024-01-04

5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01